ARTICLE | Clinical News
Clolar clofarabine: Completed Phase II enrollment
December 10, 2007 8:00 AM UTC
GENZ completed enrollment of 109 treatment-naïve AML patients who are unlikely to benefit from standard induction therapy in the pivotal, U.S. Phase II CLASSIC II trial of IV clofarabine. The agent al...